Literature DB >> 28955118

Outcomes of Venous Malformation Sclerotherapy: A Review of Study Methodology and Long-Term Results.

Sumera Ali1, Sally E Mitchell2.   

Abstract

It is very important that patients seeking sclerotherapy for the treatment of venous malformations are aware of the expected course of the therapy. They should be thoroughly counseled about the complications, the need for multiple sessions of therapy, and also about the expected clinical outcome. The aim of this review is to discuss the long-term outcomes of sclerotherapy for the treatment of venous malformation. Many studies have discussed their individual center's experiences and short-midterm results, but there is a relative paucity of data on long-term outcomes. We have reviewed the literature and also shared our experience of a large cohort of patients ( n  = 116) with a relatively longer follow-up period of more than 1 year. Venous malformations are very complex lesions and their treatment is quite variable depending on its extent and complexity. As a result, outcome studies vary considerably in the choice of sclerosant, study methodology, outcome assessment (clinical vs. imaging), and grading scales. This review also highlights this extreme heterogeneity in the literature of the sclerotherapy outcome and summarizes a few national and international studies for comparison.

Entities:  

Keywords:  interventional radiology; sclerotherapy; venous malformation

Year:  2017        PMID: 28955118      PMCID: PMC5615387          DOI: 10.1055/s-0037-1604300

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  15 in total

Review 1.  Percutaneous treatment of low flow vascular malformations.

Authors:  Patricia E Burrows; Keira P Mason
Journal:  J Vasc Interv Radiol       Date:  2004-05       Impact factor: 3.464

2.  Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.

Authors:  Kong T Tan; John Kirby; Dheeraj K Rajan; Eran Hayeems; John R Beecroft; Martin E Simons
Journal:  J Vasc Interv Radiol       Date:  2007-03       Impact factor: 3.464

3.  Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification.

Authors:  Mayank Goyal; Petrina A Causer; Derek Armstrong
Journal:  Radiology       Date:  2002-06       Impact factor: 11.105

4.  Treatment of venous malformations: first experience with a new sclerosing agent--a multicenter study.

Authors:  Martin Schumacher; Patrick Dupuy; Jean-Michel Bartoli; Ulrike Ernemann; Denis Herbreteau; Corinne Ghienne; Laurent Guibaud; Dirk A Loose; Raul Mattassi; Philippe Petit; Jochen K Rössler; Francesco Stillo; Johannes Weber
Journal:  Eur J Radiol       Date:  2011-04-01       Impact factor: 3.528

5.  Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.

Authors:  Yunbo Jin; Xiaoxi Lin; Wei Li; Xiaojie Hu; Gang Ma; Wei Wang
Journal:  J Vasc Surg       Date:  2008-04-03       Impact factor: 4.268

6.  Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations.

Authors:  Nisha Limaye; Vinciane Wouters; Melanie Uebelhoer; Marjut Tuominen; Riikka Wirkkala; John B Mulliken; Lauri Eklund; Laurence M Boon; Miikka Vikkula
Journal:  Nat Genet       Date:  2008-12-14       Impact factor: 38.330

7.  Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.

Authors:  Takashi Yamaki; Motohiro Nozaki; Hiyoyuki Sakurai; Masaki Takeuchi; Kazutaka Soejima; Taro Kono
Journal:  J Vasc Surg       Date:  2008-03       Impact factor: 4.268

8.  Percutaneous sclerotherapy for facial venous malformations: subjective clinical and objective MR imaging follow-up results.

Authors:  J Spence; T Krings; K G terBrugge; L B da Costa; R Agid
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-31       Impact factor: 3.825

9.  Long-term patient satisfaction after percutaneous treatment of peripheral vascular malformations.

Authors:  Edwin van der Linden; Peter M T Pattynama; Birthe C Heeres; Sylvia C de Jong; Wim C J Hop; Lucia J M Kroft
Journal:  Radiology       Date:  2009-03-31       Impact factor: 11.105

10.  Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans.

Authors:  Sandra D Castillo; Elena Tzouanacou; May Zaw-Thin; Inma M Berenjeno; Victoria E R Parker; Iñigo Chivite; Maria Milà-Guasch; Wayne Pearce; Isabelle Solomon; Ana Angulo-Urarte; Ana M Figueiredo; Robert E Dewhurst; Rachel G Knox; Graeme R Clark; Cheryl L Scudamore; Adam Badar; Tammy L Kalber; Julie Foster; Daniel J Stuckey; Anna L David; Wayne A Phillips; Mark F Lythgoe; Valerie Wilson; Robert K Semple; Neil J Sebire; Veronica A Kinsler; Mariona Graupera; Bart Vanhaesebroeck
Journal:  Sci Transl Med       Date:  2016-03-30       Impact factor: 17.956

View more
  1 in total

Review 1.  Imaging of benign cervicofacial vascular anomalies and associated syndromes.

Authors:  Anthony S Larson; Waleed Brinjikji; Katelyn R Anderson; Megha Tollefson; V Michelle Silvera; Julie B Guerin
Journal:  Interv Neuroradiol       Date:  2021-08-16       Impact factor: 1.764

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.